Contact Person
    Helen Pettersson

    Senior Project Manager
    Phone: (M) +45 2337 0040

    MVA Oncology Network Meeting

    Welcome to MVA Oncology Network and our 5th meeting!

    Biomarkers – opportunities and challenges in oncology drug development

    Biomarker measurements have become an essential component of oncology drug development, particularly so in this era of targeted therapies.

    What does it take to get a biomarker from discovery to translation to commercialization? Are we making the most out of the biomarker expertise we have in the Medicon Valley region? 

    Medicon Valley Alliance together with Biopeople/Biomarkers as emerging growth area now invites you to MVA Oncology Network and our 5th  meeting covering the topic “Biomarkers – opportunities and challenges in oncology drug development”:
    Date: 9 April 2018
    Time: 17:00 – 20:00
    Host: Biopeople/Biomarkers as emerging growth area
    Venue: Medicon Valley Alliance, Auditorium, Arne Jacobsens Allé 15, Ørestad City, 2300 Copenhagen
    Cost: Free of charge for MVA members

    Sign up

    The network
    MVA Oncology Network is a professional and social network within oncology. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region. The network consists of professors, PI and corporate level executives from the regional oncology eco-system. Membership is limited to Medicon Valley Alliance members only, but non-member organizations and companies are welcome to attend one network event to evaluate if a membership of the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically able you to join the oncology network.



    Registration, networking and a bite to eat – meet the fellow participants

    17:30-17.35  Welcome 
    Petter Hartman, CEO, Medicon Valley Alliance
    Jane Nøhr, Cluster Manager, BioPeople
    7:35-17:40 Sponsor of the event
    Peter Holm, Partner, European Patent Attorney, HØIBERG
    17:40-18.10 “Who are we?” 4 x 5 minute corporate presentations
    Ole Thastrup, CEO, 2cureX
    PRA Health Sciences
    18:10-18.40 Keynote Speaker
    Systems medicine methods for identification of stratified cancer therapies and their predictive biomarkers

    Krister Wennerberg, Prof., University of Copenhagen
    18:40-18.55 Biomarkers as emerging growth area
    Jane Nøhr, Cluster Manager, BioPeople
    18:55-19:10 Biomarkers as a platform for clinical success and reimbursement
    Henrik Winther, SVP Business Development, Immunovia AB
    19:10-19:30 Future joint Nordic Biomarker initiative?
    Nils Brünner, Prof., University of Copenhagen
    19:30-20:00 Structured networking and a light snack



    In collaboration

       mva logo


    logo LU logo uni_copenhagen